These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 12872363)
21. Low-level laser therapy in the prevention and treatment of chemotherapy-induced oral mucositis in young patients. Abramoff MM; Lopes NN; Lopes LA; Dib LL; Guilherme A; Caran EM; Barreto AD; Lee ML; Petrilli AS Photomed Laser Surg; 2008 Aug; 26(4):393-400. PubMed ID: 18754720 [TBL] [Abstract][Full Text] [Related]
22. Oral mucositis in childhood cancer patients receiving high-dose methotrexate: Prevalence, relationship with other toxicities and methotrexate elimination. Valer JB; Curra M; Gabriel AF; Schmidt TR; Ferreira MBC; Roesler R; Evangelista JMC; Martins MAT; Gregianin L; Martins MD Int J Paediatr Dent; 2021 Mar; 31(2):238-246. PubMed ID: 32815183 [TBL] [Abstract][Full Text] [Related]
23. Prospective evaluation of incidence and severity of oral mucositis induced by conventional chemotherapy in solid tumors and malignant lymphomas. Nishimura N; Nakano K; Ueda K; Kodaira M; Yamada S; Mishima Y; Yokoyama M; Terui Y; Takahashi S; Hatake K Support Care Cancer; 2012 Sep; 20(9):2053-9. PubMed ID: 22116139 [TBL] [Abstract][Full Text] [Related]
24. Reliability and validity of a patient self-administered daily questionnaire to assess impact of oral mucositis (OM) on pain and daily functioning in patients undergoing autologous hematopoietic stem cell transplantation (HSCT). Stiff PJ; Erder H; Bensinger WI; Emmanouilides C; Gentile T; Isitt J; Lu ZJ; Spielberger R Bone Marrow Transplant; 2006 Feb; 37(4):393-401. PubMed ID: 16415901 [TBL] [Abstract][Full Text] [Related]
26. Confounding factors associated with oral mucositis assessment in patients receiving chemoradiotherapy for head and neck cancer. Chung YL; Pui NNM Support Care Cancer; 2017 Sep; 25(9):2743-2751. PubMed ID: 28353040 [TBL] [Abstract][Full Text] [Related]
27. Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial. Karthaus M; Rosenthal C; Huebner G; Paul H; Elser C; Hertenstein B; Krauter J; Scharmann T; Geissler RG; Heil G; Ganser A Bone Marrow Transplant; 1998 Oct; 22(8):781-5. PubMed ID: 9827976 [TBL] [Abstract][Full Text] [Related]
28. Effects of an oral mucosa protective formulation on chemotherapy- and/or radiotherapy-induced oral mucositis: a prospective study. Ueno T; Yatsuoka W; Ishiki H; Miyano K; Uezono Y BMC Cancer; 2022 Jan; 22(1):90. PubMed ID: 35062896 [TBL] [Abstract][Full Text] [Related]
29. Ketamine mouthwash versus placebo in the treatment of severe oral mucositis pain in children with cancer: A randomized double-blind placebo-controlled trial. Prakash S; Meena JP; Gupta AK; Bakhshi S; Velpandian T; Pandey RM; Seth R Pediatr Blood Cancer; 2020 Sep; 67(9):e28573. PubMed ID: 32648983 [TBL] [Abstract][Full Text] [Related]
30. A comparison of dioctahedral smectite and iodine glycerin cream with topical mouth rinse in treatment of chemotherapy induced oral mucositis: a pilot study. Lin JX; Fan ZY; Lin Q; Wu DH; Wu XY; Chen YR; Fang HY; Wu DB; Wen JY; Dong M; Ma XK; Wan XB Eur J Oncol Nurs; 2015 Apr; 19(2):136-41. PubMed ID: 25465773 [TBL] [Abstract][Full Text] [Related]
31. Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy. Rosen LS; Abdi E; Davis ID; Gutheil J; Schnell FM; Zalcberg J; Cesano A; Gayko U; Chen MG; Clarke S J Clin Oncol; 2006 Nov; 24(33):5194-200. PubMed ID: 17075109 [TBL] [Abstract][Full Text] [Related]
32. Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy. Limaye SA; Haddad RI; Cilli F; Sonis ST; Colevas AD; Brennan MT; Hu KS; Murphy BA Cancer; 2013 Dec; 119(24):4268-76. PubMed ID: 24114811 [TBL] [Abstract][Full Text] [Related]
33. Patients' experiences and perceptions of chemotherapy-induced oral mucositis in a day unit. Chen HM Cancer Nurs; 2008; 31(5):363-9. PubMed ID: 18772661 [TBL] [Abstract][Full Text] [Related]
34. Validation of the oral mucositis assessment scale in pediatric cancer. Sung L; Tomlinson GA; Greenberg ML; Koren G; Judd P; Ota S; Feldman BM Pediatr Blood Cancer; 2007 Aug; 49(2):149-53. PubMed ID: 16628556 [TBL] [Abstract][Full Text] [Related]
35. Preliminary study in a new protocol for the treatment of oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation (HSCT) and chemotherapy (CT). Vitale MC; Modaffari C; Decembrino N; Zhou FX; Zecca M; Defabianis P Lasers Med Sci; 2017 Aug; 32(6):1423-1428. PubMed ID: 28664389 [TBL] [Abstract][Full Text] [Related]
36. A double-blind, placebo-controlled, randomized trial to evaluate the role of tetrachlorodecaoxide in the management of chemotherapy-induced oral mucositis. Malik IA; Moid I; Haq S; Sabih M J Pain Symptom Manage; 1997 Aug; 14(2):82-7. PubMed ID: 9262037 [TBL] [Abstract][Full Text] [Related]
37. A double blind randomised placebo controlled study of propolis (bee glue) effectiveness in the treatment of severe oral mucositis in chemotherapy treated children. Tomaževič T; Jazbec J Complement Ther Med; 2013 Aug; 21(4):306-12. PubMed ID: 23876561 [TBL] [Abstract][Full Text] [Related]